• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 5. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788

Recent Advances in the Study of 3-3-Fluoro-5-(trifluoromethoxy)-phenylpropionic acid (CAS: 1261828-37-8)

The compound 3-3-Fluoro-5-(trifluoromethoxy)-phenylpropionic acid (CAS: 1261828-37-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This fluorinated aromatic carboxylic acid derivative is being explored for its potential applications in drug discovery, particularly as a building block for novel therapeutic agents. Recent studies have focused on its unique physicochemical properties, synthetic accessibility, and biological activity profiles, making it a promising candidate for further investigation.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 3-3-Fluoro-5-(trifluoromethoxy)-phenylpropionic acid as a key intermediate in the synthesis of potent G protein-coupled receptor (GPCR) modulators. The researchers highlighted how the compound's trifluoromethoxy and fluorine substituents contribute to enhanced metabolic stability and improved membrane permeability of resulting drug candidates. These findings suggest potential applications in central nervous system (CNS) drug development where such properties are particularly valuable.

Structural activity relationship (SAR) studies involving this compound have revealed interesting insights into the role of fluorine substitution patterns in biological activity. Research teams at several pharmaceutical companies have incorporated 3-3-Fluoro-5-(trifluoromethoxy)-phenylpropionic acid into their lead optimization programs, reporting improved pharmacokinetic profiles in preclinical models. The compound's ability to serve as a bioisostere for various pharmacophores has expanded its utility across multiple therapeutic areas.

Recent synthetic chemistry advances have also improved the production scalability of 3-3-Fluoro-5-(trifluoromethoxy)-phenylpropionic acid. A 2024 paper in Organic Process Research & Development described an optimized manufacturing route that significantly reduces production costs while maintaining high purity standards. This development is particularly important as demand for this building block increases in both academic and industrial research settings.

Emerging applications in radiopharmaceutical development have also been reported, where the fluorine-18 labeled version of this compound is being evaluated as a potential positron emission tomography (PET) tracer. Preliminary studies suggest good brain penetration and suitable pharmacokinetics for imaging applications, opening new avenues for diagnostic agent development.

As research continues, 3-3-Fluoro-5-(trifluoromethoxy)-phenylpropionic acid demonstrates growing importance in medicinal chemistry. Its versatility as a synthetic intermediate combined with favorable physicochemical properties positions it as a valuable tool for drug discovery programs targeting various disease areas, including neurological disorders, inflammatory conditions, and metabolic diseases.

• 1352999-94-0(3-Fluoro-5-(trifluoromethoxy)phenylacetic acid)
• 1261554-07-7(3-[5-Fluoro-2-(trifluoromethoxy)phenyl]propionic acid)
• 916420-57-0(3-[3-Methyl-5-(trifluoromethoxy)phenyl]propionic acid)
• 886499-74-7(3-4-(Trifluoromethoxy)phenylpropanoic Acid)
• 168833-77-0(3-(Trifluoromethoxy)hydrocinnamic Acid)
• 1092460-96-2(3-5-Fluoro-2-(trifluoromethoxy)-phenylpropionic acid)
• 1261874-77-4(3-(3-Fluoro-5-methoxyphenyl)propanoic acid)
• 1261830-54-9(Methyl 3-(3'-(difluoromethoxy)-5'-fluorophenyl)propionate)
• 1240256-80-7(3-4-Fluoro-3-(trifluoromethoxy)-phenylpropionic acid)
• 1240257-16-2(3-2-Fluoro-4-(trifluoromethoxy)-phenylpropionic acid)